8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione-13C,D3; (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl-4-13C-4,4,4-D3)-3-methyl-1-((5-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione;Linagliptin-13C-D3
Linagliptin-13C-d3 is a fully characterized chemical compound used as a reference standard of API Linagliptin. The standard offered is compliant with regulatory guidelines. Linagliptin-13C-d3 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1398044-43-3
